Clinical trial
BRCA Founder OutReach (BFOR) Study
NCT03351803 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BRCA Founder OutReach (BFOR) Study
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 10, 2017
- Completion date
- May 10, 2027
- Enrollment
- 5,412 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
brca1 mutation, brca2 mutation